Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators

Autor: Jesse Weinberger, Roger E. Kelley, Gary J. Martin, Camilo R. Gomez, Connie J. Hockersmith, Karl B. Kern, Elizabeth Gandara, Richard L. Koller, William P. Wright, Cheryl C. Farmer, Thomas A. Buckingham, Waclav M. Jagiella, Gerald V. Nacarelli, Julie Hoff, Donald D. Brown, Lisa Kaufmann, Barbara J. Green, Charles H. Presti, Susan M. Newburg, Harold P. Adams, Cathy M. Helgason, John Chanc, José Biller, Scott C. Litin, Steven L. Kopecky, Lillian Cristo, J. Ghali, Anne D. Leonard, Scott R. Bundlie, George T. Kondos, Howard C. Dittrich, Robert M. Redd, Carann A. Easton, Elia S. Quiroga, Johnf Rothrock, Arthur J. Labovit, Christopher P. Appleton, Robert M. Rothbart, George Feldman, William M. Feinberg, Pat Stevenson, David O. Wiebers, William T. Bardsley, Valentin Fuster, Susan Kreher, Carolyn Burkhardt, Gretchen H. Bailey, John A. Byer, Nathan Blank, Laura M. Isensee, David C. Anderson, Brenda K. Void, Scott W. Sharkey, Denise L. Janosik, Diane M. Miller, Rebecca S. Bacon, Odalys Perez, Jonathan L. Halperin, Elizabeth B. Rothlauf, Dorothy J. Cadell, William R. Logan, Gage Van Horn, Martin E. Goldman, Vincent T. Miller, Ellis Eugene Marsh, Anne E. Holland, R. P. McRae, R. R. Rabjohns, Maite Palermo, Barbie Nolte, Victoria L. Mitchell, Douglas M. Zerbe, Richard W. Asinger, Ruth McBride, K. Wang, Greg C. Flaker, Richard Goldman, Charles H. Tegeler, Deborah Grimm Wilson, Bruce M. Coull, Ernest O. Theilen, Arthur D. Hayward, James H. Chesebro, Bruce A. Cohen, William P. Hamilton, Ileana L. Pina, Robert A. Chahine, Carol Hagenhoff, Richard Webel, John H. McAnulty, Sara J. Sirna, Charles R. Jorgensen, Alan J. Pawlow, Christy Marchant, Merrill C. Kanter, J. Donald Easton

Publikováno v: Stroke. 21(4)

Individuals with nonvalvular atrial fibrillation are at increased risk of stroke. The Stroke Prevention in Atrial Fibrillation Study is a 15-center randomized clinical trial examining the risks and benefits of low-intensity warfarin (prothrombin time

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4d0b9a25d1eda4fb6f676b560eb2c00
https://pubmed.ncbi.nlm.nih.gov/2183405